PRECLINICAL ARTICLES
-
Years Before Clinical Trials: The Decisions That Shape The Future Of Academic Cancer Discoveries
David Adler, MD, Ph.D., MBA, explains how earlier collaboration between academic and pharma researchers can strengthen oncology discoveries that lead to clinical trials.
-
Metabolic Interventions Improve Cancer Treatment Delivery
Could effective drug delivery depend not only on getting more therapy into a tumor but also on changing the tumor’s biological response to treatment?
-
Where Are Dermatology's Next Competitive Battles Taking Shape?
EADV 2026 highlighted how leaders in dermatology are looking to maintain their leadership in diseases such as PsO and AD while expanding their portfolios into smaller therapeutic areas.
-
Rewiring BCL6 To Trigger Cell Death
Shenandoah is rewiring oncogenic drivers, specifically BCL6, to bypass resistance and directly trigger the cell’s natural self-destruct machinery.
-
Using Recurring Toxicity Profiles To Inform Preclinical Study Design
In this preliminary analysis of regulatory reviews, toxicity profiles were constructed from nonclinical animal findings.
-
Drug Discovery's Hidden Feedback Loop
Some of the most valuable insights may not come from the next experiment, but from past experiments.
PRECLINICAL ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Early mRNA-LNP formulation decisions influence in vivo CAR-T delivery, expression, repeat-dose tolerability, stability, scalability, and manufacturing flexibility, shaping therapeutic performance and downstream development risk.
-
Optimizing LNPs for in vivo CAR-T requires aligning target selection, formulation design, and delivery performance to achieve functional CAR expression in desired T-cell populations while balancing specificity, safety, dosing flexibility, and manufacturability.
-
Lipids that shift charge with pH can be chosen to fit the application and delivery route. Varied pKa and biodegradability give developers room to match each therapeutic target.
-
Ionizable lipid selection ratios shape how well lipid nanoparticles deliver nucleic acids, and empirical testing shows that similar physical properties can still produce very different performance.
-
Uncover how EPR spectroscopy fills the conformational gap by capturing dynamic protein motions, refining Cryo-EM models, and revealing hidden structural ensembles for drug discovery.
-
Explore how EPR-based distance measurement techniques differ in implementation, optimization, and strengths, as well as which sample characteristics can help determine the most suitable approach.
-
Gain insight into how EPR spectroscopy reveals protein dynamics, validates structural models, supports Cryo-EM sample screening, and characterizes GPCR conformational changes.
-
Protein structures are not static. See how conformational changes influence physiological function and how electron paramagnetic resonance spectroscopy provides insights into effective design.
-
See how EPR extends structural analysis beyond conventional NMR constraints by revealing long-range distances, conformational heterogeneity, paramagnetic centers, and more.
-
Missing cryo-EM density does not always indicate disorder. Learn how flexibility, conformational variation, incomplete occupancy, and sample heterogeneity can shape what is visible in a protein structure.
-
Discover how pulsed dipolar EPR complements NMR by revealing protein flexibility, conformational changes, and ligand-induced dynamics, including low-population states that can be difficult to resolve.
-
Gene expression profiling reveals whether engineered T cells display intended molecular changes while helping identify unwanted effects. See how a standardized workflow can improve consistency.
PRECLINICAL SOLUTIONS
-
The NanoAssemblr™ Ignite and Ignite+ systems provide an easy-to-use, scalable platform for reproducible lipid nanoparticle formulation. Choose the workflow and cartridge-use approach that fits your program today, with a validated path to clinical and commercial manufacturing when you are ready.
-
Protein dynamics can expose critical gaps between computational predictions and biological behavior. Learn how experimentally measuring conformational states can strengthen model validation.
-
Our custom expression platform directly addresses the primary host limitations in early-to-mid stage assay development:
-
Automated nucleic acid purification can deliver high throughput without limiting flexibility or consuming valuable bench space. See how adaptable workflows support efficient sample preparation.
-
Combine precise manual control with rapid repeat dispensing in one instrument. One-handed volume adjustment, intuitive controls, and flexible charging help streamline liquid handling.
-
Regulatory-aligned off-target risk assessment for genome editing programs, from early guide RNA screening through IND-enabling confirmation studies, structured to support FDA submission requirements.
-
Software for Automated, Digitalized Experimentation
Katalyst D2D® (Design-to-Decide) provides integrated experiment design, planning, execution, and analysis for high-throughput synthesis, process optimization, and preformulation studies. It helps scientists execute experiments more efficiently and connect data with decisions across the design-make-test-analyze (DMTA) cycle.
-
Magnetic bead-based genomic DNA extraction kit.
-
Frees you from routine pipetting and provides excellent results
-
We have introduced the MAG and HEATMAG modules with you, the scientists, in mind.
-
MAGFLO magnetic beads are only available in Austria, Belgium, Denmark, France, Germany, Ireland, Netherlands, Sweden, Switzerland and the United Kingdom.
-
Explore how a data‑driven discovery model combines DEL screening, computational insights, and medicinal chemistry to accelerate hit‑to‑lead decisions, reduce risk, and enable efficient progression.
-
Chemomics transforms full DEL datasets into predictive insights. See how combining large-scale screening with clear computational models accelerates SAR understanding and strengthens confidence.
-
Generate human-relevant data with an Organ-Chip system that combines automation, imaging, and cost efficiency for faster, more confident insights for drug development and complex biological studies.